The Society for Inherited Metabolic Disorders (SIMD) works to increase awareness of inborn errors of metabolism with a focus on research and support for interactions between clinicians and investigators in the field.
Travere at SIMD 2024
Travere Therapeutics was honored to participate in this year’s event and engage with all the metabolic experts. We look forward to seeing you next year.
Program
Economic Burden of Classical Homocystinuria in the United States
Speakers: Mahim Jain, Lionel Pinto, Mehul Shah, Andrew Rava, Colette Ndiba-Markey, Diana Amari
Contact Your Travere MSL
Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.
Contact an MSLClinical Burden of Classical Homocystinuria in the United States: A Retrospective Claims Analysis
Speakers: Queenie Paltanwale, Mahim Jain, Lionel Pinto, Mehul Shah, Magdaliz Gorritz, Dajun Tian, Kevin Hawkins, Andrew Rava, Colette Ndiba-Markey, Diana Amari
Association Between Homocystiene and Clinical Outcomes in Patients With Classical Homocystinuria: A Systematic Literature Review
Speakers: Mehul Shah, Marissa Betts, Sophie Yoon, Lionel Pinto, Sarah Ronnebaum
Latest Results From the COMPOSE® Phase 1/2 Trial for the Treatment of Classical Homocystinuria (HCU) Using Pegtibatinase, A Novel Investigational Enzyme Replacement Therapy
Speakers: Jaya Ganesh, Janet Thomas, Wendy E. Smith, Melissa Lah, David Kudrow, Jalé Güner, Sharon McDermott, Sagar A. Vaidya, Liz Wilkening, Harvey Levy, Can Ficicioglu
Pegtibatinase, an Investigational Enzyme Replacement Therapy, for the Treatment of Classical Homocystinuria (HCU): Design of the HARMONY Phase 3 Study
Speakers: Janet Thomas, Tawfeg Ben-Omran, Harvey Levy, François Maillot, Sharon McDermott, Sergio Slawka, Can Ficicioglu
MA-DS-24-0023 | August 2024